Want to see SE:ITECH full AI Analyst Report?
ITECH Stock Chart & Stats
kr53.80
-kr1.50(-1.91%)
At close: 4:00 PM EST
kr53.80
-kr1.50(-1.91%)
Day’s Range― - ―
52-Week Rangekr42.20 - kr124.50
Previous CloseN/A
Volume8.40K
Average Volume (3M)30.18K
Market Cap
kr815.85M
Enterprise Valuekr667.55M
Total Cash (Recent Filing)kr156.70M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)23.4
Beta-0.18
Next Earnings
Aug 21, 2026Next Dividend Ex-DateN/A
Dividend Yield1.84%
Share Statistics
EPS (TTM)2.90
Shares Outstanding11,997,777
10 Day Avg. Volume43,174
30 Day Avg. Volume30,179
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)3.58
Price to Sales (P/S)3.71
P/FCF Ratio9.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)3.73
Revenue Forecast (FY)kr197.00M
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet (near-zero Debt)Near-zero debt gives durable financial flexibility: the company can fund commercialization, absorb cyclical shipping-market weaknesses and prioritize R&D or partner development without significant interest burden. Low leverage materially reduces insolvency risk and supports multi‑quarter resilience.
Strong Profitability And MarginsSustained TTM profitability and solid margins indicate scalable unit economics for Selektope sales and licensing. Positive earnings after a multi‑year step‑up show operational efficiency, enabling reinvestment into commercial expansion or partner programs without eroding margins.
Proprietary Product Addressing Structural Market NeedSelektope is a differentiated bio‑repellent for antifouling coatings, matching long‑term industry trends toward fuel efficiency and hull performance. A proprietary ingredient plus a sales/licensing model can produce durable revenue streams as coating makers adopt higher‑performance formulations.
Bears Say
Recent Revenue Decline / Cooling GrowthTop-line contraction after rapid 2022–2024 growth signals a normalization or loss of momentum. Persistent revenue decline would limit scale economies, constrain reinvestment in commercialization, and make it harder to translate product differentiation into sustained market share gains.
Declining Free Cash Flow And Cash VolatilityMeaningful FCF decline and historical volatility reduce internal funding available for partner development, approvals and marketing. Weaker cash conversion increases the probability of external financing needs and complicates multi‑period commercialization planning.
Concentration On Partner Adoption And Regulatory ApprovalsRevenue depends heavily on coating manufacturers adopting Selektope and obtaining regulatory approvals. Slow uptake, long approval timelines, or concentrated partner wins create execution and regulatory concentration risks that can delay or cap long‑term scale for the specialist product.
ITECH FAQ
What was I-Tech AB’s price range in the past 12 months?
I-Tech AB lowest stock price was kr42.20 and its highest was kr124.50 in the past 12 months.
What is I-Tech AB’s market cap?
I-Tech AB’s market cap is kr815.85M.
When is I-Tech AB’s upcoming earnings report date?
I-Tech AB’s upcoming earnings report date is Aug 21, 2026 which is in 27 days.
How were I-Tech AB’s earnings last quarter?
I-Tech AB released its earnings results on May 07, 2026. The company reported kr1.4 earnings per share for the quarter, beating the consensus estimate of kr0.83 by kr0.57.
Is I-Tech AB overvalued?
According to Wall Street analysts I-Tech AB’s price is currently Overvalued.
Does I-Tech AB pay dividends?
I-Tech AB pays a Notavailable dividend of kr1.25 which represents an annual dividend yield of 1.84%. See more information on I-Tech AB dividends here
What is I-Tech AB’s EPS estimate?
I-Tech AB’s EPS estimate is 1.
How many shares outstanding does I-Tech AB have?
I-Tech AB has 11,997,777 shares outstanding.
What happened to I-Tech AB’s price movement after its last earnings report?
I-Tech AB reported an EPS of kr1.4 in its last earnings report, beating expectations of kr0.83. Following the earnings report the stock price went up 3.175%.
Which hedge fund is a major shareholder of I-Tech AB?
Currently, no hedge funds are holding shares in SE:ITECH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
I-Tech AB
I-Tech AB, a biotechnology firm established in Mölndal, Sweden, in 2000, focuses on creating and commercializing products to prevent biofouling. Their flagship innovation is Selektope, a unique bio-repellent ingredient engineered for marine coatings. This compound provides crucial protection against hard fouling on ships, primarily by temporarily stimulating the swimming behavior of barnacle larvae, thereby preventing them from attaching to coated surfaces. The company's primary clientele is the marine coatings industry.